Biologics

artigo científico

mentions

First seen: há 4 mesesLast seen: há 12 dias

wikidata

Recent News4

permanente.org·há 14 dias

How Permanente Medicine is helping unlock the promise of biosimilars

Maisha Draves, MD, MPH, explains the potential of biosimilars in health care to expand access, improve affordability, and create better outcomes. The post How Permanente Medicine is helping unlock the

benefitscanada.com·há 4 meses

Weight management drugs, rare disease treatments expected to drive private drug plan costs in 2026: report

Weight management drugs and high-cost specialty treatments are expected to have the biggest impact on private drug plans this year, according to Telus Health’s annual drug pipeline report. It fo

journals.seedstm.com·há 5 meses

[Cost-Consequence Analysis of Vedolizumab Initiation Timing Strategies in Crohn’s Disease in Italy]

BACKGROUND: Moderate-to-severe Crohn’s disease (CD) significantly impacts patients and the healthcare system. Timely initiation of biologic therapy is crucial for clinical outcomes and economic effici

acuitysurgical.com

Biologics - Acuity Surgical

AcuPure™ Fiber is a gamma-irradiated, sterile human tissue allograft consisting of 100% human demineralized bone allograft. These allografts function as a bone void filler to support bone repair. Acu

Related Entities

1Biosimilars25×
2Employer Benefits24×
3Canada24×
4Claims Data Analysis24×
5Drug Plans24×
6Employee Well-Being24×
7Generic Drugs24×
8Generic Drug Pricing24×
9Chronic Disease24×
10Drug Plan Design24×

Biologics — Entidade | Buobe